Karl Nobert

Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food

and drug industries for pharmaceuticals and OTC drugs, biologics, medical devices. He has vast

experience in the areas of regenerative medicine and has counseled numerous clients seeking FDA approval for cellular-based products to treat both humans and animals.